CTI Life Sciences Fund

Summary

In 2006 was created CTI Life Sciences Fund, which is appeared as VC. The fund was located in North America if to be more exact in Canada. The leading representative office of defined VC is situated in the Montru00e9al.

Among the most successful fund investment fields, there are Pharmaceutical, Medical Device. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular portfolio startups of the fund, we may highlight SutroVax, Enobia Pharma, NeurAxon. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Besides them, we counted 11 critical employees of this fund in our database.

Considering the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2018. The fund is constantly included in 2-6 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. This CTI Life Sciences Fund works on 1 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2017.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the CTI Life Sciences Fund, startups are often financed by Yaletown Partners, Polaris Partners, Flagship Pioneering. The meaningful sponsors for the fund in investment in the same round are Fonds de solidaritu00e9 FTQ, BDC Healthcare Venture, Yaletown Partners. In the next rounds fund is usually obtained by BDC Healthcare Venture, Yaletown Partners, Vertex Ventures HC.